Skip to main content
OpenTrials

Clinical trial condition

Hormone Refractory Prostatic Cancer

Explore clinical trials studying Hormone Refractory Prostatic Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Hormone Refractory Prostatic Cancer trial results

Completed

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT05848011

Conditions
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Neoplasms, Androgen-Insensitive Prostatic Cance, +17 more
Locations
  • United Medical Group Miami, Florida, United States
  • Orlando Health Cancer Institute Orlando, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 61 locations
View Trial Details

Related conditions